fda tirzepatide shortage update today says this weight loss drug is over, but patients worry about cost and availability FDA facing blowback after ending

Obesity Reviews, 24 (3), 437-450

It is important to note that NHS availability of these medicines remains subject to local commissioning decisions and specialist service capacity

Common side effects (affecting up to 1 in 10 people): Vomiting Constipation Abdominal pain or discomfort Dyspepsia (indigestion) Decreased appetite Hypoglycaemia (low blood sugar), particularly when used in combination with insulin or sulphonylureas Injection site reactions (redness, itching, or bruising) Less common but important side effects: Acute pancreatitis: Characterised by severe, persistent abdominal pain that may radiate to the back

236 (1), e13857

"The skin is getting darker and my growing hair is changing and getting curly and more dark," she shared